Project Grant R25CA291637
Award Date
8/8/24
Completion Date
7/31/29
Dollars Obligated
$389K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Cancer Institute
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
The National Cancer Institute (NCI) awarded Emory University a $312,737 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program. The "Georgia Science Education Initiative NCI YES (GA-YES)" program aims to recruit and train high school students underrepresented in STEM careers, with a focus on rural and lower socioeconomic status students, in cancer research and disparities. Key program components include: 1) a summer mentored cancer research training...
The National Institute of General Medical Sciences (NIGMS) awarded a $268,734 Project Grant (CFDA 93.859 Biomedical Research and Research Training) to the University of Chicago for the "SHE (SUMMER HEALTHCARE EXPERIENCE) IN ONCOLOGY" program. This virtual, multi-institutional STEM enrichment program aims to increase participation of women from underrepresented backgrounds in the cancer biomedical workforce. The program provides high school students with hands-on research experience,...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $170,640 in funding to the Dana-Farber Cancer Institute, Inc. (DFCI) from July 1, 2025 to June 30, 2027. The grant supports research to investigate the role of histone cleavage in breast cancer, specifically focusing on how the KDM4C histone demethylase drives tumor growth by preventing proteolytic cleavage of the histone H3 N-terminal tail by cathepsin L. The research aims to...
The National Cancer Institute (NCI) awarded a $178,444 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the University of California, Los Angeles (UCLA) for the "UCLA SURGEON-SCIENTIST BASIC CANCER RESEARCH TRAINING PROGRAM (UCLA SURGEON-SCIENTIST BCRTP)". The program aims to provide rigorous curriculum and mentored research experiences to exceptional surgical residents dedicated to advancing cancer research and treatment innovation. The program...
The Project Grant award R35CA293978, provided by the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research), supports research to identify the mechanisms driving rapid evolution of cancer genomes. The $942,442 award to the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, MA will fund investigations into two catastrophic mutational processes in cancer, chromothripsis and chromoplexy. The research aims to better understand the mechanisms of chromosome fragmentation, DNA...
This Project Grant award of $603,803 from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) will support research by the University of Massachusetts Boston to investigate the biomechanical and biomolecular properties of large extracellular vesicles (L-EVs) and their potential as cancer biomarkers. The collaborative project aims to advance microfluidic technology to measure single L-EV characteristics and explore the clinical utility of multiplex L-EV profiling from plasma...
The Defense Health Agency has awarded a $1,780,000 Project Grant titled "SUPPORTING UNDERREPRESENTED POPULATIONS IN GENOMICS-BASED CANCER TRIAL ENROLLMENT (SURGE)" to the Dana-Farber Cancer Institute, Inc. in Boston, MA. This award, funded through the Military Medical Research and Development program (CFDA 12.420), will support cancer research focused on improving enrollment of underrepresented populations in genomics-based clinical trials. The grant period runs from July 1, 2024 to...
The National Cancer Institute (NCI) awarded a $514,196 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, MA. The grant, which runs from September 1, 2024 to April 2, 2027, will support research to investigate IGF2BP1 as a novel therapeutic target for Ewing sarcoma, the second most prevalent bone cancer among children. The project aims to validate IGF2BP1 as an Ewing sarcoma dependency, determine the molecular...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $193,144 to The Trustees of Columbia University in the City of New York to support a multidisciplinary postdoctoral training program focused on gastrointestinal (GI) cancers. The 5-year program, running from September 1, 2024 to August 31, 2029, aims to train the next generation of GI cancer researchers across basic science, translational, clinical, epidemiological, and...
This Project Grant award of $223,176 from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports research to define the role of stress granules in cancer initiation. The primary awardee, The Children's Hospital Corporation doing business as Boston Children's Hospital, will leverage a humanized zebrafish melanoma model to investigate how stress granules formed in melanoma precursor cells impact tumor development and progression. The research aims to elucidate the...